Next Biomedical Co.,Ltd. (KOSDAQ:389650)

South Korea flag South Korea · Delayed Price · Currency is KRW
92,400
+1,800 (1.99%)
Last updated: Dec 9, 2025, 10:59 AM KST
142.20%
Market Cap739.17B
Revenue (ttm)14.90B
Net Income (ttm)-117.78M
Shares Out8.20M
EPS (ttm)-606.21
PE Ration/a
Forward PE258.23
Dividendn/a
Ex-Dividend Daten/a
Volume47,632
Average Volume200,701
Open93,500
Previous Close90,600
Day's Range89,700 - 93,600
52-Week Range35,500 - 101,000
Betan/a
RSI66.78
Earnings DateMar 13, 2026

About Next Biomedical

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 389650
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.